BAKER BROS. ADVISORS LP – Adaptimmune Therapeutics plc Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$10.56M
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
-36.76%
quarter
Adaptimmune Therapeutics plc 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -6.14M | $1.08 | 9.83M | |
| Q2 2022 | share | 0.00% | 0 shares | -3.54M | $1.7 | 9.83M | |
| Q1 2022 | share | 0.00% | 0 shares | -16.61M | $2.06 | 9.83M | |
| Q4 2021 | share | 0.00% | 0 shares | -13.96M | $3.87 | 9.83M | |
| Q3 2021 | share | 0.00% | 0 shares | 8.94M | $5.17 | 9.83M | |
| Q2 2021 | share | 0.00% | 0 shares | -10.32M | $4.26 | 9.83M | |
| Q1 2021 | share | 0.00% | 0 shares | -786K | $5.31 | 9.83M | |
| Q4 2020 | share | Increase | +55.30% | 3.50M shares | 2.47M | $5.39 | 9.83M |
| Q3 2020 | share | Decrease | -5.17% | -344.82K shares | -16.30M | $7.98 | 6.33M |
| Q2 2020 | share | Increase | +80.88% | 2.98M shares | 56.78M | $10.01 | 6.67M |
| Q1 2020 | share | Increase | 0.00% | 3.69M shares | 10.03M | $2.72 | 3.69M |
| Q3 2018 | share | Decrease | -100.00% | -100K shares | -1.18M | $13.56 | 0 |
| Q2 2018 | share | 0.00% | 0 shares | 64K | $11.87 | 100K | |
| Q1 2018 | share | 0.00% | 0 shares | 455K | $11.23 | 100K | |
| Q4 2017 | share | 0.00% | 0 shares | -151K | $6.68 | 100K | |
| Q3 2017 | share | 0.00% | 0 shares | 370K | $8.19 | 100K | |
| Q2 2017 | share | 0.00% | 0 shares | -102K | $4.49 | 100K | |
| Q1 2017 | share | 0.00% | 0 shares | 146K | $5.51 | 100K | |
| Q4 2016 | share | 0.00% | 0 shares | -300K | $4.05 | 100K | |
| Q3 2016 | share | 0.00% | 0 shares | -110K | $7.05 | 100K | |
| Q2 2016 | share | 0.00% | 0 shares | 2K | $8.15 | 100K | |
| Q1 2016 | share | 0.00% | 0 shares | -393K | $8.13 | 100K |